Top Suppliers:I want be here
  • BioBioPha
  • China
  • Product Name: Riboflavine
  • Price: ￥Inquiry/5mg
  • Purity: 98.0%
  • Stocking Period: 10 Day
  • Contact: Xueping-Zheng
Related CAS#:
83-88-5 13123-37-0
5984-80-5 53797-35-6
146-17-8 34469-63-1
26193-20-4 108020-62-8
101652-10-2 752-56-7
1773508-83-0 1984055-22-2
1158522-08-7 940364-43-2
1807120-60-0 80699-76-9
134104-43-1 131615-57-1
6906-52-1 930439-75-1

83-88-5

83-88-5 structure
83-88-5 structure
  • Name: Riboflavine
  • Chemical Name: Riboflavin (B2)
  • CAS Number: 83-88-5
  • Molecular Formula: C17H20N4O6
  • Molecular Weight: 376.364
  • Catalog: API Vitamins and minerals Vitamin B drugs
  • Create Date: 2018-02-05 08:00:00
  • Modify Date: 2024-01-02 16:46:04
  • Riboflavin is an easily absorbed micronutrient with a key role in maintaining health in humans and other animals.Target: OthersRiboflavin (vitamin B2) is the direct precursor of redox enzyme cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which are essential for multiple cell physiology [1]. Urinary excretion of riboflavin contributes to one-half of the overall removal of riboflavin from plasma. No sex differences were observed for any of the pharmacokinetic variables (P > 0.05) [2]. Riboflavin, similar to other vitamins of the B complex, presents anti-inflammatory activity but its full characterization has not yet been carried out. Riboflavin (25, 50 or 100 mg/kg, i.p.), administered immediately and 2 h after the injection of carrageenan, induced antiedema and antinociceptive effects. The antinociceptive effect was not inhibited by the pretreatment with cadmium sulfate (1 mg/kg), an inhibitor of flavokinase. Riboflavin (50 or 100 mg/kg, i.p., 0 and 2 h) also inhibited the fever induced by lipopolysaccharide (LPS) in rats. Riboflavin is a safe drug, is approved for clinical use and exacerbates the antinociceptive effect of morphine, may warrant clinical trials to assess its potential in the treatment of different painful or inflammatory conditions [3].
Name Riboflavin (B2)
Synonyms 6,7-dimethyl-9-D-ribitylisoalloxazine
riboflavine
D-Ribitol, 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-
Flavin BB
Hibon
1-Deoxy-1-(4-hydroxy-7,8-dimethyl-2-oxobenzo[g]pteridin-10(2H)-yl)-D-ribitol
D-Ribitol, 1-deoxy-1-(4-hydroxy-7,8-dimethyl-2-oxobenzo[g]pteridin-10(2H)-yl)-
Russupteridine Yellow III
VITAMIN B2
(-)-Riboflavin
Lactoflavin
Riboflavin (B2)
Beflavin
MFCD00005022
BEFLAVINE
1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol
EINECS 201-507-1
1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-D-ribitol
riboflavin
EINECS 201-507-1
Description Riboflavin is an easily absorbed micronutrient with a key role in maintaining health in humans and other animals.Target: OthersRiboflavin (vitamin B2) is the direct precursor of redox enzyme cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which are essential for multiple cell physiology [1]. Urinary excretion of riboflavin contributes to one-half of the overall removal of riboflavin from plasma. No sex differences were observed for any of the pharmacokinetic variables (P > 0.05) [2]. Riboflavin, similar to other vitamins of the B complex, presents anti-inflammatory activity but its full characterization has not yet been carried out. Riboflavin (25, 50 or 100 mg/kg, i.p.), administered immediately and 2 h after the injection of carrageenan, induced antiedema and antinociceptive effects. The antinociceptive effect was not inhibited by the pretreatment with cadmium sulfate (1 mg/kg), an inhibitor of flavokinase. Riboflavin (50 or 100 mg/kg, i.p., 0 and 2 h) also inhibited the fever induced by lipopolysaccharide (LPS) in rats. Riboflavin is a safe drug, is approved for clinical use and exacerbates the antinociceptive effect of morphine, may warrant clinical trials to assess its potential in the treatment of different painful or inflammatory conditions [3].
Related Catalog
References

[1]. Long, Q., et al., Riboflavin biosynthetic and regulatory factors as potential novel anti-infective drug targets. Chem Biol Drug Des, 2010. 75(4): p. 339-47.

[2]. Zempleni, J., J.R. Galloway, and D.B. McCormick, Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr, 1996. 63(1): p. 54-66.

[3]. Bertollo, C.M., et al., Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models. Eur J Pharmacol, 2006. 547(1-3): p. 184-91.
Density 1.7±0.1 g/cm3
Boiling Point 715.6±70.0 °C at 760 mmHg
Melting Point 290 °C (dec.)(lit.)
Molecular Formula C17H20N4O6
Molecular Weight 376.364
Flash Point 386.6±35.7 °C
Exact Mass 376.138275
PSA 161.56000
LogP -2.01
Vapour Pressure 0.0±2.4 mmHg at 25°C
Index of Refraction 1.733
Storage condition 2~8°C
Water Solubility 0.07 g/L (20 ºC)

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VJ1400000
CHEMICAL NAME :
Riboflavine
CAS REGISTRY NUMBER :
83-88-5
LAST UPDATED :
199701
DATA ITEMS CITED :
11
MOLECULAR FORMULA :
C17-H20-N4-O6
MOLECULAR WEIGHT :
376.41
WISWESSER LINE NOTATION :
T C666 BN DNVMV INJ B1YQYQYQ1Q L1 M1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
560 mg/kg
TOXIC EFFECTS :
Behavioral - food intake (animal) Kidney, Ureter, Bladder - urine volume decreased Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
Sex chromosome loss and nondisjunction
TEST SYSTEM :
Rodent - hamster Lung
DOSE/DURATION :
100 mg/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 373,1,1997 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 67410 No. of Facilities: 1890 (estimated) No. of Industries: 8 No. of Occupations: 22 No. of Employees: 24319 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 67410 No. of Facilities: 2923 (estimated) No. of Industries: 15 No. of Occupations: 45 No. of Employees: 74790 (estimated) No. of Female Employees: 35023 (estimated)
Symbol GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
Signal Word Danger
Hazard Statements H225-H301 + H311 + H331-H370
Precautionary Statements P210-P260-P280-P301 + P310-P311
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes F,T
Risk Phrases 11-23/24/25-39/23/24/25
Safety Phrases S24/25
RIDADR UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany 1
RTECS VJ1400000
HS Code 2936230000
HS Code 2936230000
Summary 2936230000. unmixed vitaming b2 and deratives(whether or not dissolved in solvents). VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:4.0%. General tariff:20.0%

Chemsrc provides CAS#:83-88-5 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 83-88-5 | Chemsrc address: https://www.chemsrc.com/en/baike/951941.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved